The Reappraisal of the Reappraisal-CRAC Channels Are Activated by L-Type Ca Channel Blockers, Reply to Bird Et Al
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Rajagopal S, Rosenberg P
. Overcoming Confounding to Characterize the Effects of Calcium Channel Blockers. Function (Oxf). 2023; 4(6):zqad054.
PMC: 10568197.
DOI: 10.1093/function/zqad054.
View
2.
Zhang W, Halligan K, Zhang X, Bisaillon J, Gonzalez-Cobos J, Motiani R
. Orai1-mediated I (CRAC) is essential for neointima formation after vascular injury. Circ Res. 2011; 109(5):534-42.
PMC: 3164514.
DOI: 10.1161/CIRCRESAHA.111.246777.
View
3.
Wright J, Boudinot F, Ujhelyi M
. Measurement and analysis of unbound drug concentrations. Clin Pharmacokinet. 1996; 30(6):445-62.
DOI: 10.2165/00003088-199630060-00003.
View
4.
Johnson M, Gudlur A, Zhang X, Xin P, Emrich S, Yoast R
. L-type Ca channel blockers promote vascular remodeling through activation of STIM proteins. Proc Natl Acad Sci U S A. 2020; 117(29):17369-17380.
PMC: 7382247.
DOI: 10.1073/pnas.2007598117.
View
5.
Verkhratsky A, Petersen O
. How Do We Clean Up the Scientific Record?. Function (Oxf). 2023; 4(6):zqad055.
PMC: 10568198.
DOI: 10.1093/function/zqad055.
View